EQS-News: aap Implantate AG / Schlagwort(e): Zulassungsgenehmigung/Sonstiges Fortschritte im MDR-Prozess – aap erhält MDR-Zertifikat 27.01.2025 / 14:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Die aap Implantate AG („aap“ oder „Gesellschaft“) konnte einen weiteren wichtigen Meilenstein in Richtung Übergang von MDD (Medical Device Directive 93/42/EWG) hin zur MDR (Medical Device Regulation EU 2017/745) erreichen und im Anschluss an das im September 2024 erfolgreich durchgeführte Audit mit ihrer Benannten Stelle das MDR-Zertifika...
EQS-News: aap Implantate AG / Key word(s): Regulatory Approval/Miscellaneous Progress in the MDR process - aap receives MDR certificate 27.01.2025 / 14:00 CET/CEST The issuer is solely responsible for the content of this announcement. aap Implantate AG ("aap" or "Company") has reached another important milestone in the transition from MDD (Medical Device Directive 93/42/EEC) to MDR (Medical Device Regulation EU 2017/745) and received the MDR certificate for its quality system following the successful audit with its Notified Body in September 2024. The first medical devic...
Mainz Biomed N.V. Regains Compliance with Nasdaq Capital Market Listing Requirements BERKELEY, Calif. and MAINZ, Germany, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed NV (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today that on January 23, 2025, the Company received formal notice from The Nasdaq Stock Market LLC (“Nasdaq”) confirming that it has regained compliance with the minimum stockholders’ equity requirement for continued listing on the Nasdaq Capital Market set forth in Listing R...
Franklin Electric Declares Payment of Increased Quarterly Cash Dividend FORT WAYNE, Ind., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Franklin Electric Co., Inc. (NASDAQ: FELE) announced today that its Board of Directors declared a quarterly cash dividend of $0.265 per share payable February 20, 2025, to shareholders of record on February 6, 2025. This represents a 6 percent increase from the prior quarterly dividend. This dividend will mark the 33rd consecutive year that Franklin Electric has increased its dividend, demonstrating its commitment to returning cash to shareholders and confidence in ...
Bicara Therapeutics Presents Phase 1/1b Dose Expansion Results with Ficerafusp Alfa in Advanced Squamous Cancer of the Anal Canal at the 2025 ASCO Gastrointestinal Cancers Symposium BOSTON, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, today announced the presentation of data from the Phase 1/1b dose expansion cohort of ficerafusp alfa in combination with pembrolizumab in patients with second line (2L) or later squamous cancer o...
CINCINNATI--(BUSINESS WIRE)-- Fifth Third (NASDAQ: FITB) customers can receive tax refunds via direct deposit up to five days early, for free, with a account.1 Fifth Third is one of the only banks in the country to offer this service to customers. Getting customers tax refunds up to five days early is just one way Fifth Third challenges what is possible, making banking a Fifth Third Better®. According to the IRS, nine out of ten consumers who file electronically and who choose to receive their refund by direct deposit get their money in less than 21 days. Fifth Third cuts that wait time by ...
TopBuild to Release Fourth Quarter and Year End 2024 Results on Tuesday, February 25 Conference Call and Webcast at 9:00 A.M. ET DAYTONA BEACH, Fla., Jan. 27, 2025 (GLOBE NEWSWIRE) -- TopBuild Corp. (NYSE:BLD), a leading installer and specialty distributor of insulation and building material products to the construction industry in the United States and Canada, will release its fourth quarter and year end 2024 results prior to 7:00 a.m. on Tuesday, February 25. The Company will host a conference call at 9:00 a.m. Eastern time that same day to review its financial results. To participat...
Supernus Announces Label Update for Non-Stimulant ADHD Treatment, Qelbree®, Including New Pharmacodynamic Data and Information for Breastfeeding Women Updated label includes new data in Section 12.2, detailing serotonin 5-HT2C partial agonist activity and norepinephrine transporter inhibition, highlighting Qelbree’s multimodal pharmacodynamicsQelbree is the first ADHD treatment to meet its post marketing requirement and receive labeling approval following the 2019 FDA guidance on Clinical Lactation Studies1 ROCKVILLE, Md., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals,...
Oxford Lane Capital Corp. Announces Net Asset Value and Selected Financial Results for the Third Fiscal Quarter and Declaration of Distributions on Common Stock for the Months Ending April, May, and June 2025 GREENWICH, Conn., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Oxford Lane Capital Corp. (Nasdaq: OXLC) (NasdaqGS: OXLCP) (NasdaqGS: OXLCL) (NasdaqGS: OXLCO) (NasdaqGS: OXLCZ) (NasdaqGS: OXLCN) (NasdaqGS: OXLCI) (“Oxford Lane,” the “Company,” “we,” “us” or “our”) announced today the following financial results and related information: On January 24, 2025, our Board of Directors declared the f...
Cannara Biotech annonce des produits et une part de marché nationale records pour le premier trimestre 2025, ouvrant la voie à un élan continu en 2025 Produits records : Des produits nets de 25,1 millions de dollars au T1 2025, soit une augmentation de 29 % par rapport aux 19,5 millions de dollars du T1 2024, grâce à une forte demande de produits de cannabis de qualité supérieure.Part de marché record : Part de marché record de 4,1 % au Canada1, soit une augmentation de 28 % d’un trimestre à l’autre et de 58 % par rapport à la même période de l'année précédente, avec des gains dans toutes l...
Cannara Biotech Reports Record Q1 2025 Revenue and National Market Share, Sets Stage for Continued Momentum in 2025 Record Revenue: Net revenues of $25.1 million in Q1 2025, a 29% increase compared to $19.5 million in Q1 2024, driven by strong demand for Cannara’s premium-grade cannabis products.Record Market Share: Achieved Canadian market share of 4.1%1, representing a 28% increase quarter over quarter, and 58% increase over the same period of prior year with gains across all licensed provinces.Robust Profitability: Gross profit before fair value adjustments grew 23% to $9.8 million in Q1...
SeaStar Medical Adds Fifth Hospital Customer for QUELIMMUNE DENVER, Jan. 27, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: ICU), a commercial-stage therapeutic medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, has shipped QUELIMMUNE™ to a California medical center recognized as a world leader in pediatric research and treatments, increasing commercial customers to five. QUELIMMUNE is the company’s Selective Cytopheretic Device (SCD) for treating critically ill children in the intensive care unit (ICU) with acute kidney injury (AK...
Benitec Biopharma to Participate in Upcoming Conferences in January and February HAYWARD, Calif., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary “Silence and Replace” DNA-directed RNA interference ("ddRNAi") platform, today announced that its management team will participate in the following upcoming conferences. Muscular Dystrophy Association Gene Therapy SummitDates: January 28 – 30, 2025Location: Tucson, AZ ...
Arcutis to Present at the Guggenheim SMID Cap Biotech Conference WESTLAKE VILLAGE, Calif., Jan. 27, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that Arcutis management will participate in the Guggenheim SMID Cap Biotech Conference, taking place February 5-6, 2025. Details for the company’s participation are as follows: Fireside Chat Date: Thursday, February 6, 2025 Fireside Chat Time: 1:00 pm ET The webcast for this conference may be accessed at th...
Enphase Energy Announces Technology Integration into Octopus Energy Smart Tariff Program in the United Kingdom FREMONT, Calif., Jan. 27, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, announced today that the Enphase® Energy System has integrated into Octopus Energy’s smart tariffs, such as “Intelligent Octopus Flux” (IO Flux), which can save customers money on electricity bills. Last year, Enphase a new strategic relationship with Octopus to deploy IQ8™ Microinverters and IQ...
iCAD Pre-Announces Estimated Q4 2024 Revenue iCAD to Participate in the BTIG at Snowbird:12th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference NASHUA, N.H., Jan. 27, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”), a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast health solutions, today reported select preliminary, unaudited financial results for the fourth quarter of 2024. Based on preliminary, unaudited financial information, the Company expects total revenue ...
Stereotaxis Receives CE Mark Approval for the MAGiC Ablation Catheter ST. LOUIS, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it received European CE Mark approval for the MAGiC™ ablation catheter. This approval is a significant milestone for Stereotaxis and for the community of physicians pioneering robotics in electrophysiology. It is reflective of the company’s commitment to advancing significant innovations that make robotics increasingly impactful acr...
MASS Coalition Welcomes Trump Order Freezing Skin Substitute LCDs FLORHAM PARK, N.J., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Celularity issues the following announcement on behalf of the members of the MASS Coalition: MASS Coalition Welcomes Trump Order Freezing Skin Substitute LCDsPresident Trump’s Freeze Order Applies to Skin Substitute LCDs – LCDs will not be effective until at least April 13, 2025 The MASS Coalition applauds President Trump for his bold action ordering a freeze of all regulatory guidance not yet in effect, which includes the recent Medicare Local Coverage Determinations ...
GDC Discontinues Livestreaming Gaming Business NEW YORK, Jan. 27, 2025 (GLOBE NEWSWIRE) -- GD Culture Group Limited (“GDC” or the “Company”) (Nasdaq: GDC), and its subsidiary, AI Catalysis Corp. (“AI Catalysis”), today announced its decision to discontinue its online livestreaming gaming business after conducting a comprehensive assessment. While this decision marks a significant shift, previously released games and related content will remain operational but will no longer receive updates. The move aligns with the Company's broader strategy to optimize resources and focus on areas with ...
Entera Bio to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference JERUSALEM, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and therapeutic proteins, announced that it will participate and be available for investor meetings at the Oppenheimer 35th Annual Healthcare Life Sciences Conference being held February 11 – 12, 2025 in a virtual format. The presentation scheduled for Tuesday, February 11th at 12:40-1:10 PM ET in Track 1 will feature a business overview and...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.